LSV Asset Management
SUPN icon

LSV Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

LSV Asset Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$284K Hold
6,100
– – ﹤0.01% 791
2026
Q1 		$315K Hold
6,100
– – ﹤0.01% 744
2025
Q4 		$303K Hold
6,100
– – ﹤0.01% 742
2025
Q3 		$292K Buy
+6,100
New +$246K ﹤0.01% 752
2023
Q3 		– Sell
-22,400
Closed -$673K – 892
2023
Q2 		$673K Hold
22,400
– – ﹤0.01% 731
2023
Q1 		$812K Sell
22,400
-2,200
-9% -$84.6K ﹤0.01% 679
2022
Q4 		$877K Hold
24,600
– – ﹤0.01% 664
2022
Q3 		$833K Sell
24,600
-3,100
-11% -$101K ﹤0.01% 662
2022
Q2 		$801K Hold
27,700
– – ﹤0.01% 702
2022
Q1 		$895K Sell
27,700
-700
-2% -$21.5K ﹤0.01% 716
2021
Q4 		$828K Sell
28,400
-8,800
-24% -$267K ﹤0.01% 727
2021
Q3 		$992K Sell
37,200
-156,500
-81% -$4.2M ﹤0.01% 714
2021
Q2 		$5.96M Sell
193,700
-830,600
-81% -$25.5M 0.01% 528
2021
Q1 		$26.8M Buy
1,024,300
+2,400
+0.2% +$67.1K 0.05% 328
2020
Q4 		$25.7M Buy
1,021,900
+210,100
+26% +$4.52M 0.05% 331
2020
Q3 		$16.9M Buy
811,800
+115,434
+17% +$2.62M 0.03% 354
2020
Q2 		$16.5M Sell
696,366
-3,900
-0.6% -$86.2K 0.03% 371
2020
Q1 		$12.6M Buy
700,266
+8,900
+1% +$187K 0.03% 373
2019
Q4 		$16.4M Buy
691,366
+20,337
+3% +$494K 0.03% 412
2019
Q3 		$18.4M Buy
671,029
+650,329
+3,142% +$19.3M 0.03% 386
2019
Q2 		$684K Buy
+20,700
New +$709K ﹤0.01% 793

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

LSV Asset Management's SUPN Position: Q2 2026 in Review

LSV Asset Management held its Supernus Pharmaceuticals (SUPN) position steady in Q2 2026 at 6,100 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #791.

LSV Asset Management first reported a position in SUPN in Q2 2019 and has held it in 21 quarters since. The position peaked at $26.8M in Q1 2021. 139 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • LSV Asset Management held 6,100 shares of Supernus Pharmaceuticals worth $284K as of Q2 2026.
  • LSV Asset Management left its Supernus Pharmaceuticals share count unchanged in Q2 2026.
  • Supernus Pharmaceuticals made up ﹤0.01% of LSV Asset Management's portfolio in Q2 2026, its #791 holding.
  • LSV Asset Management first reported a position in Supernus Pharmaceuticals in Q2 2019 and has held it in 21 quarters since.
  • LSV Asset Management's Supernus Pharmaceuticals position peaked at $26.8M in Q1 2021.
  • 139 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on LSV Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.